The U.S. housing market is expected to deteriorate further in 2026, with no rebound in sight. Rising competition from new ...

Novo Nordisk has lost GLP-1 leadership against Eli Lilly. Click here to read more about NVO stock and why it is a Hold.

Buy: $80 12-month target. Record Q1 2026 growth, margin resilience, AI efficiency gains & leverage drop—see valuation, risks ...

Ubtech Robotics is transitioning from an AI humanoid concept to commercialized hardware. Read why we are bullish on UBTRF ...

Michael Burry of “The Big Short” fame said he holds no position in SpaceX ( SPCX ). Despite raising doubts about the ...

Micron is experiencing unprecedented demand for DRAM, NAND, HBM, and enterprise SSDs. Find out why I rate MU stock a Buy.

Navan stock rebounds after IPO and Q1 beat, but valuation looks stretched and AI disruption risk looms. Here's what investors ...

Skyworks is being priced like a tired handset supplier, but I think that view is too narrow. Click here to read why SWKS ...

Blue Bird's accretive Micro Bird JV acquisition supports long-term profitable growth prospects. But read why BLBD stock is ...

The PGIM Jennison Utility Fund advanced though underperformed the 8.3% return of the S&P 500 Utilities Index for the first ...

Double-digit revenue growth across core segments and AWS's 28% YoY growth reinforce Amazon's diversified business model. See ...

Bunge stock is downgraded as the risk/reward profile has shifted after the explosive rally, though I remain bullish long-term ...